116 related articles for article (PubMed ID: 38556072)
1. Alterations of UHRF family Expression and was regulated by High Risk Type HPV16 in Uterine Cervical Cancer.
Yoshimoto M; Tokuda A; Eguchi A; Nozawa Y; Mori T; Yaginuma Y
Exp Cell Res; 2024 Apr; 437(2):114018. PubMed ID: 38556072
[TBL] [Abstract][Full Text] [Related]
2. Alterations of UHRF Family Expression and UHRF1/ICBP90 Inhibits Phosphatase and Tensin Homolog Expression in Endometrial Cancer.
Yoshimoto M; Tokuda A; Eguchi A; Nozawa Y; Mori T; Yaginuma Y
Oncology; 2023; 101(7):457-468. PubMed ID: 37263260
[TBL] [Abstract][Full Text] [Related]
3. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
4. UHRF1 silences gelsolin to inhibit cell death in early stage cervical cancer.
Lee HJ; Kim MJ; Kim YS; Choi MY; Cho GJ; Choi WS
Biochem Biophys Res Commun; 2020 Jun; 526(4):1061-1068. PubMed ID: 32312517
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
6. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
7. UHRF1 Induces Methylation of the
Kim MJ; Lee HJ; Choi MY; Kang SS; Kim YS; Shin JK; Choi WS
Mol Cells; 2021 Mar; 44(3):146-159. PubMed ID: 33795533
[TBL] [Abstract][Full Text] [Related]
8. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.
Hasan UA; Bates E; Takeshita F; Biliato A; Accardi R; Bouvard V; Mansour M; Vincent I; Gissmann L; Iftner T; Sideri M; Stubenrauch F; Tommasino M
J Immunol; 2007 Mar; 178(5):3186-97. PubMed ID: 17312167
[TBL] [Abstract][Full Text] [Related]
9. Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer.
D S P; Chaturvedi PK; Krishnamoorthy D; Seo YS; Thippana M; Park WY
PLoS One; 2022; 17(4):e0266532. PubMed ID: 35421154
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
11. Identification of host transcriptional networks showing concentration-dependent regulation by HPV16 E6 and E7 proteins in basal cervical squamous epithelial cells.
Smith SP; Scarpini CG; Groves IJ; Odle RI; Coleman N
Sci Rep; 2016 Jul; 6():29832. PubMed ID: 27457222
[TBL] [Abstract][Full Text] [Related]
12. GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer.
Ma C; Zeng C; Jin L; Yang Y; Li P; Chen L; Wang J
Sci Rep; 2015 Nov; 5():16555. PubMed ID: 26560046
[TBL] [Abstract][Full Text] [Related]
13. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
14. The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?
Bronner C; Achour M; Arima Y; Chataigneau T; Saya H; Schini-Kerth VB
Pharmacol Ther; 2007 Sep; 115(3):419-34. PubMed ID: 17658611
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
[TBL] [Abstract][Full Text] [Related]
16. UHRF1 epigenetically down-regulates UbcH8 to inhibit apoptosis in cervical cancer cells.
Zhang Q; Qiao L; Wang X; Ding C; Chen JJ
Cell Cycle; 2018; 17(3):300-308. PubMed ID: 29157076
[TBL] [Abstract][Full Text] [Related]
17. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
18. HPV E7 affects the function of cervical cancer cells via the TAL1/lnc‑EBIC/KLHDC7B axis.
Wang J; Xiang F; Liu X; Ma X; Cai X; Yang Y; Shen X; Yuan C; Xiang Y; Xiao H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760214
[TBL] [Abstract][Full Text] [Related]
19. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
[TBL] [Abstract][Full Text] [Related]
20. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
